Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine May/22/2021 48 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 46
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
Remdesivir Approved by FDA Experimental Antiviral Apr/21/2021 62 5
Convalescent plasma Emergency use authorization Experimental Antiviral Apr/10/2021 37 6
mRNA-1273 Emergency use authorization Experimental Vaccine Apr/08/2021 22 0
Salinomycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021 5 1
Silibinin Potential treatment - theoretical effect Natural product Antiviral Apr/06/2021 2 0
Arbidol Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/03/2021 14 3
Adjuvanted SARS-CoV-2 Spike protein Potential treatment - pre-clinical evidence Experimental Vaccine Apr/01/2021 4 0